NE
NASDAQ · NEUP
Neuphoria Therapeutics Inc.
Healthcare · Medical - Pharmaceuticals
$3.78
Down-$0.04 (-1.06%)
Updated Sep 16, 2026, 9:11 PM
SID Score
3.3/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.4M
- P/E ratio
- -0.02
- Dividend yield
- 0.00%
- 52-week range
- $3.19 – $5.53
- Volume
- 17.69K
- Avg. volume
- 1.58M
Price performance
NEUP price history
1M range · 20 trading sessions · Daily adjusted prices
NEUP closed at $3.78 after 20 trading sessions, down 5.03% for the selected period.
- Last close
- $3.78
- Period change
- -5.03%
- Period low
- $3.73
- Period high
- $3.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $3.75 | $3.80 | $3.73 | $3.78 | 17.69K |
| Sep 14, 2026 | $3.78 | $3.84 | $3.74 | $3.80 | 12.52K |
| Sep 11, 2026 | $3.78 | $3.78 | $3.72 | $3.73 | 23.04K |
| Sep 10, 2026 | $3.79 | $3.7925 | $3.70 | $3.73 | 42.99K |
| Sep 9, 2026 | $3.795 | $3.8647 | $3.75 | $3.75 | 18.61K |
| Sep 8, 2026 | $3.84 | $3.84 | $3.72 | $3.75 | 22.6K |
| Sep 4, 2026 | $3.74 | $3.78 | $3.73 | $3.77 | 21.95K |
| Sep 3, 2026 | $3.84 | $3.84 | $3.7418 | $3.76 | 7.46K |
| Sep 2, 2026 | $3.84 | $3.84 | $3.75 | $3.75 | 17.95K |
| Sep 1, 2026 | $3.73 | $3.81 | $3.73 | $3.79 | 20.83K |
| Aug 31, 2026 | $3.71 | $3.815 | $3.71 | $3.76 | 52.2K |
| Aug 28, 2026 | $3.72 | $3.835 | $3.72 | $3.76 | 29.91K |
| Aug 27, 2026 | $3.84 | $3.90 | $3.71 | $3.77 | 50.11K |
| Aug 26, 2026 | $3.86 | $3.995 | $3.8537 | $3.86 | 41.03K |
| Aug 25, 2026 | $3.93 | $3.96 | $3.85 | $3.86 | 33.65K |
| Aug 24, 2026 | $3.8999 | $4.0101 | $3.8999 | $3.95 | 58.03K |
| Aug 21, 2026 | $3.9799 | $4.05 | $3.91 | $3.91 | 179.82K |
| Aug 20, 2026 | $3.98 | $4.00 | $3.92 | $3.95 | 55.68K |
| Aug 19, 2026 | $4.03 | $4.03 | $3.93 | $3.93 | 24K |
| Aug 18, 2026 | $3.85 | $4.34 | $3.83 | $3.98 | 240.46K |
Latest NEUP news
The latest Smart Investors Daily articles mentioning NEUP.
Stock researchMarket Activity · Institutional Ownership
Loading stock research…
